Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrilutamide gel Phase 1/2 in mild to moderate acne vulgaris
CTR20210427Phase 2Completed
- Sponsor
- Suzhou Kaixi Pharmaceutical
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyrilutamide in acne vulgaris, sponsored by Suzhou Kaixi Pharmaceutical. Started Mar 2021; status: completed.
02
Drugs
pyrilutamide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20210427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210427.